NCT03181308 2020-06-24Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLCTracon Pharmaceuticals Inc.Phase 1 Completed11 enrolled 11 charts
NCT03780010 2019-10-28Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLCTracon Pharmaceuticals Inc.Phase 1 Completed15 enrolled 14 charts